title: Thalidomide as a treatment for refractory CGD colitis.
authors.forename: Harry
authors.initials: H
authors.lastname: Sokol
authors.forename: Felipe
authors.initials: F
authors.lastname: Suarez
authors.forename: Tchao
authors.initials: T
authors.lastname: Meatchi
authors.forename: Georgia
authors.initials: G
authors.lastname: Malamut
authors.forename: Marie-Anne
authors.initials: MA
authors.lastname: Pocidalo
authors.forename: Stephane
authors.initials: S
authors.lastname: Blanche
authors.forename: Christophe
authors.initials: C
authors.lastname: Cellier
authors.forename: Olivier
authors.initials: O
authors.lastname: Hermine
mesh_terms: D001706:Biopsy; D003092:Colitis / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006105:Granulomatous Disease, Chronic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide